Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Paladin Labs has acquired Tempra line of products from Bristol Myers Squibb in Canada including both syrup and drop formulations, under an agreement signed between both the companies.
Subscribe to our email newsletter
Paladin’s product line includes both over-the-counter (OTC) and prescription drugs such as Zincofax for diaper rash, Anbesol for teething, Cerumol for ear wax removal, Twinject for anaphylaxis, and Kaeopectate for diarrhea.
Paladin president and CEO Jonathan Ross Goodman said Tempra has strong brand equity in Canada among parents and physicians.
"Building on our existing distribution activities, Tempra will prove synergistic and provide additional critical mass and strategic options for further developing our Canadian OTC presence," Goodman said.